TELA BIO INC's ticker is TELA and the CUSIP is 872381108. A total of 33 filers reported holding TELA BIO INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,697,400 | -33.8% | 337,175 | -16.1% | 0.51% | -5.4% |
| Q2 2023 | $4,072,422 | +2.9% | 402,016 | +8.1% | 0.54% | +34.8% |
| Q1 2023 | $3,956,048 | -33.9% | 371,809 | -28.5% | 0.40% | +29.4% |
| Q4 2022 | $5,980,909 | +35.0% | 520,079 | 0.0% | 0.31% | +20.7% |
| Q3 2022 | $4,431,000 | +13.8% | 520,079 | -6.4% | 0.26% | +13.3% |
| Q2 2022 | $3,895,000 | -41.0% | 555,623 | -2.1% | 0.23% | +5.6% |
| Q1 2022 | $6,599,000 | -8.6% | 567,420 | +0.6% | 0.21% | -18.3% |
| Q4 2021 | $7,221,000 | -8.9% | 564,120 | -2.8% | 0.26% | +8.7% |
| Q3 2021 | $7,930,000 | -35.0% | 580,515 | -23.4% | 0.24% | -36.6% |
| Q2 2021 | $12,204,000 | +94.5% | 757,524 | +79.8% | 0.38% | +112.3% |
| Q1 2021 | $6,276,000 | +34.9% | 421,202 | +36.2% | 0.18% | +5.9% |
| Q4 2020 | $4,652,000 | -2.6% | 309,323 | +7.2% | 0.17% | -31.3% |
| Q3 2020 | $4,774,000 | – | 288,605 | – | 0.25% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Essex Woodlands Management, Inc. | 4,110,709 | $19,320,332 | 6.30% |
| Stonepine Capital Management, LLC | 625,645 | $2,940,532 | 2.70% |
| AIGH Capital Management LLC | 1,656,655 | $7,786,278 | 2.42% |
| Velan Capital Investment Management LP | 746,087 | $3,506,609 | 2.01% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 1,000,000 | $4,700,000 | 1.11% |
| PERKINS CAPITAL MANAGEMENT INC | 204,350 | $960 | 0.90% |
| Nantahala Capital Management | 2,445,667 | $11,494,635 | 0.68% |
| Meros Investment Management, LP | 152,718 | $717,775 | 0.34% |
| PARADIGM CAPITAL MANAGEMENT INC/NY | 1,256,200 | $5,904,140 | 0.27% |
| Orbimed Advisors | 2,457,542 | $11,550,447 | 0.23% |